EVISA - Who we are
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
Information - Pharmacy/Pharmacology
Cisplatin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Cisplatin is classified as an "alkylating agent." (For more detail, see "How Cisplatin Works" section below).
See the complete list of deadlines!
PittCon 2019: 70th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy
FESTEM 2019: 7th International Symposium of the Federation of European Societies on Trace Elements and Minerals together with 35th Annual GMS Meeting
... more Events
What's new on EVISA's web site ?
Chromium Isotope Ratio as a Tool to Track the Redox State of the Earth
Human health in dire straits if urgent actions are not made to protect the environment, warns landmark UN report
EU court rules Commission authorisation of lead chromate pigments was illegal
Impressions from the European Winter Conference on Plasma Spectrochemistry that took place February 3-8, 2017 in Pau (France)
... more News
You have forgotten your password ?
© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )